EPB42
protein-codingerythrocyte membrane protein band 4.2, the group of Transglutaminases
Gene summary
Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~23.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012985
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0019350
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012985
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Due to anemia, individuals may require transfusions and/or splenectomy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EPB42 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001114134.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 38 | 2 | 44 | ||
| missense | 1 | 5 | 147 | 21 | 174 | |
| nonsense | 3 | 2 | 5 | |||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 10 | 1 | 13 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 7 | 17 | 154 | 59 | 2 | 239 |
Highest pathogenic variant AF is 0.00008920728
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001107606.1 | 13 | MANE Select | |
| Ensembl | ENSP00000396616.2 | 13 | MANE Select | |
| RefSeq | NP_000110.2 | 13 | Standard | |
| Ensembl | ENSP00000444699.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- cell morphogenesis
- cytoskeleton organization
- regulation of cell shape
- peptide cross-linking
- hemoglobin metabolic process
Molecular Function
- protein-glutamine gamma-glutamyltransferase activity
- structural constituent of cytoskeleton
- protein binding
- ATP binding
Cellular Component
- cytoskeleton
- plasma membrane
- cortical cytoskeleton
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000300215
- Coding exons
- 13
- Length
- 115059
- Individuals with no LoFs
- 125689
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 59
- Defined
- 125748
- p
- 0.000235
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.939 | 348 | 401 | 0.868 | 0.0000241 | 4669 |
| Missense (PolyPhen) | 89 | 122.81 | 0.7247 | 1552 | ||
| Synonymous | 0.669 | 151 | 162 | 0.933 | 0.00000980 | 1484 |
| Loss of Function | 2.63 | 19 | 36.1 | 0.527 | 0.00000202 | 391 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00049 | 0.00049 | rare |
| Finnish | 0.00032 | 0.00032 | rare |
| European (Non-Finnish) | 0.00019 | 0.00018 | rare |
| South Asian | 0.00033 | 0.00033 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probably plays an important role in the regulation of erythrocyte shape and mechanical properties.;
- Disease
- DISEASE: Spherocytosis 5 (SPH5) [MIM:612690]: Spherocytosis is a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. Absence of band 4.2 associated with spur or target erythrocytes has also been reported. {ECO:0000269|PubMed:10406914, ECO:0000269|PubMed:1558976, ECO:0000269|PubMed:7772513, ECO:0000269|PubMed:7819064, ECO:0000269|PubMed:8547071, ECO:0000269|PubMed:8547605}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- LoFtool
- 0.299
- RVIS EVS
- -0.19
- RVIS percentile EVS
- 39.24
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.281
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |